Screener
Kinsale Capital Group KNSL Life Sciences — Gross written premiums
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Kinsale Capital Group in its filing.
Tagged under the XBRL concept us-gaap:PremiumsWrittenGross.
The source filing: Kinsale Capital Group’s 10-K, filed February 20, 2026.
- Filed
- Feb 20, 2026, 4:12 PM EST
- Fiscal year
- FY2025
- Accession
- 0001669162-26-000015
| Line item | Year Ended December 31, 2025 | Year Ended December 31, 2024 | Year Ended December 31, 2023 |
|---|---|---|---|
| Commercial Auto | 48,721 | 35,047 | 19,050 |
| Energy | 46,102 | 42,710 | 38,637 |
| Excess Professional | 41,453 | 32,633 | 24,033 |
| Life Sciences | 35,284 | 36,252 | 41,379 |
| Inland Marine | 33,525 | 27,184 | 18,669 |
| Professional Liability | 33,091 | 35,104 | 36,087 |
| Environmental | 31,559 | 30,372 | 25,938 |
| Health Care | 25,821 | 23,179 | 20,378 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Kinsale Capital Group's life sciences — gross written premiums?
- Kinsale Capital Group (KNSL) reported life sciences — gross written premiums of $8.82M in Q4 2025.
- How has Kinsale Capital Group's life sciences — gross written premiums changed year-over-year?
- Kinsale Capital Group's life sciences — gross written premiums decreased by 2.7% year-over-year, from $9.06M to $8.82M.
- What is the long-term trend for Kinsale Capital Group's life sciences — gross written premiums?
- Over 4 years (2021 to 2025), Kinsale Capital Group's life sciences — gross written premiums has grown at a -3.4% compound annual growth rate (CAGR), from $40.49M to $35.28M.
- What does life sciences — gross written premiums mean?
- This metric represents the total premiums generated from insurance policies underwritten within the life sciences sector, covering risks such as medical devices, pharmaceuticals, and biotechnology. It serves as a key indicator of the company's market penetration and underwriting appetite within this specialized, high-complexity industry vertical. Tracking this figure helps investors assess the growth trajectory and competitive positioning of the company's specialty insurance offerings relative to broader healthcare market trends.
Ask your AI about Kinsale Capital Group's life sciences — gross written premiums.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude